Literature DB >> 20399140

Evaluation of QuickVue influenza A+B rapid test for detection of pandemic influenza A/H1N1 2009.

John Mark S Velasco1, Maribel L Montesa-Develos, Richard G Jarman, Ma Nila B Lopez, Robert V Gibbons, Maria Theresa G Valderama, In-Kyu Yoon.   

Abstract

BACKGROUND: A novel influenza A/H1N1 emerged in early 2009 and by June 2009 was declared a pandemic by WHO. Rapid influenza antigen detection tests have been used to diagnose seasonal influenza but have not been adequately evaluated for the pandemic strain among all age groups. In the Philippines, pandemic influenza A/H1N1 2009 was first detected in May 2009 and by July 2009, 3207 cases and 6 deaths were reported.
OBJECTIVES: Using RT-PCR as the gold standard, clinical sensitivity/specificity of Quidel QuickVue (QV) influenza A+B was estimated across all age groups for pandemic influenza A/H1N1 using nasal swabs in a hospital setting. Effect of age, viral titers (Ct values), and timing of collection on QV sensitivity to detect pandemic influenza A/H1N1 2009 was also determined. STUDY
DESIGN: Febrile patients with influenza-like illness (n=360) at the V. Luna General Hospital, Manila from 1 June to 31 August 2009 were included. Nasal swabs were tested using QV and RT-PCR.
RESULTS: Of 360 nasal specimens 226 (63%) were positive for pandemic influenza A/H1N1. QV sensitivity was 63% (95% confidence interval (CI): 56-69%), specificity was 96% (95% CI: 91-99%), positive predictive value was 97% (CI: 93-99%), and negative predictive value was 57% (95% CI: 49-64%). Patient's age, fever severity, presenting symptoms or number of symptoms did not significantly affect QV sensitivity, however QV sensitivity was correlated with decreasing Ct values.
CONCLUSION: QuickVue demonstrated moderate sensitivity for pandemic influenza A/H1N1 infection. There was a significant inverse association between Ct values and QV sensitivity for pandemic influenza A/H1N1. Copyright 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20399140     DOI: 10.1016/j.jcv.2010.03.010

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


  12 in total

Review 1.  The role of rapid antigen testing for influenza in the era of molecular diagnostics.

Authors:  Suzanne E Dale
Journal:  Mol Diagn Ther       Date:  2010-08-01       Impact factor: 4.074

2.  Poor positive accuracy of QuickVue rapid antigen tests during the influenza A (H1N1) 2009 pandemic.

Authors:  Heather L Stevenson; Michael J Loeffelholz
Journal:  J Clin Microbiol       Date:  2010-08-18       Impact factor: 5.948

Review 3.  Two years after pandemic influenza A/2009/H1N1: what have we learned?

Authors:  Vincent C C Cheng; Kelvin K W To; Herman Tse; Ivan F N Hung; Kwok-Yung Yuen
Journal:  Clin Microbiol Rev       Date:  2012-04       Impact factor: 26.132

4.  Evaluation of a rapid diagnostic test, NanoSign® Influenza A/B Antigen, for detection of the 2009 pandemic influenza A/H1N1 viruses.

Authors:  Gyu-Cheol Lee; Eun-Sung Jeon; Won-Shik Kim; Dung Tien Le; Jong-Ha Yoo; Chom-Kyu Chong
Journal:  Virol J       Date:  2010-09-20       Impact factor: 4.099

5.  Duplex molecular assay intended for point-of-care diagnosis of influenza A/B virus infection.

Authors:  Liang-Ta Wu; Isabelle Thomas; Martin D Curran; Joanna S Ellis; Surendra Parmar; Neha Goel; Pia I Sharma; Jean-Pierre Allain; Helen H Lee
Journal:  J Clin Microbiol       Date:  2013-07-12       Impact factor: 5.948

6.  Detection of 2009 pandemic influenza A(H1N1) virus Infection in different age groups by using rapid influenza diagnostic tests.

Authors:  Fengxiang Gao; Carol Loring; Michael Laviolette; Denise Bolton; Elizabeth R Daly; Christine Bean
Journal:  Influenza Other Respir Viruses       Date:  2011-11-24       Impact factor: 4.380

7.  Influenza surveillance from November 2008 to 2011; including pandemic influenza A(H1N1)pdm09 in Bhutan.

Authors:  Sonam Wangchuk; Binay Thapa; Sangay Zangmo; Richard G Jarman; Piraya Bhoomiboonchoo; Robert V Gibbons
Journal:  Influenza Other Respir Viruses       Date:  2012-07-20       Impact factor: 4.380

8.  Clinical and laboratory predictors of influenza infection among individuals with influenza-like illness presenting to an urban Thai hospital over a five-year period.

Authors:  Kathryn B Anderson; Sriluck Simasathien; Veerachai Watanaveeradej; Alden L Weg; Damon W Ellison; Detchvijitr Suwanpakdee; Chonticha Klungthong; Thipwipha Phonpakobsin; Phirangkul Kerdpanich; Danabhand Phiboonbanakit; Robert V Gibbons; Stefan Fernandez; Louis R Macareo; In-Kyu Yoon; Richard G Jarman
Journal:  PLoS One       Date:  2018-03-07       Impact factor: 3.240

9.  Diagnostic performance of immunochromatography assay for rapid detection of IgM and IgG in coronavirus disease 2019.

Authors:  Jung-Yoon Choe; Ji-Won Kim; Hyun Hee Kwon; Hyo-Lim Hong; Chi Young Jung; Chang-Ho Jeon; Eun-Jin Park; Seong-Kyu Kim
Journal:  J Med Virol       Date:  2020-06-09       Impact factor: 2.327

10.  Comparison of a laboratory-developed RT-PCR and the CDC RT-PCR protocol with rapid immunodiagnostic testing during the 2009 H1N1 influenza A pandemic.

Authors:  Robert Steven Liao; Olfert Landt; Joseph Thaddeus Hill
Journal:  Diagn Microbiol Infect Dis       Date:  2011-03-09       Impact factor: 2.803

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.